Cargando…

Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic Stenosis

Lipoprotein(a) (Lp(a)) is one of the most important risk factors for the development of calcific aortic valve stenosis (CAVS). However, the mechanisms through which Lp(a) causes CAVS are currently unknown. Our objectives were to characterize the Lp(a) proteome and to identify proteins that may be di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourgeois, Raphaëlle, Bourgault, Jérôme, Despres, Audrey-Anne, Perrot, Nicolas, Guertin, Jakie, Girard, Arnaud, Mitchell, Patricia L., Gotti, Clarisse, Bourassa, Sylvie, Scipione, Corey A., Gaudreault, Nathalie, Boffa, Michael B., Koschinsky, Marlys L., Pibarot, Philippe, Droit, Arnaud, Thériault, Sébastien, Mathieu, Patrick, Bossé, Yohan, Arsenault, Benoit J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307014/ https://www.ncbi.nlm.nih.gov/pubmed/34357353 http://dx.doi.org/10.3390/metabo11070459

Ejemplares similares

A Comparative Analysis of the Lipoprotein(a) and Low-Density Lipoprotein Proteomic Profiles Combining Mass Spectrometry and Mendelian Randomization
por: Bourgeois, Raphaëlle, et al.
Publicado: (2020)

Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis
por: Bourgeois, Raphaëlle, et al.
Publicado: (2020)

Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel pathogenic mechanism for lipoprotein(a)
por: Cho, Taewoo, et al.
Publicado: (2013)

Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9
por: Romagnuolo, Rocco, et al.
Publicado: (2017)

Lipoprotein(a), Oxidized Phospholipids, and Aortic Valve Microcalcification Assessed by 18F-Sodium Fluoride Positron Emission Tomography and Computed Tomography
por: Després, Audrey-Anne, et al.
Publicado: (2019)

Phenome-wide analyses establish a specific association between aortic valve PALMD expression and calcific aortic valve stenosis
por: Li, Zhonglin, et al.
Publicado: (2020)

Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progression
por: Girard, Arnaud, et al.
Publicado: (2023)

Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
por: Zheng, Kang H., et al.
Publicado: (2019)

Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease–Free Survival, and Mortality Risk: A Mendelian Randomization Analysis
por: Arsenault, Benoit J., et al.
Publicado: (2020)

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement( )
por: Kronenberg, Florian, et al.
Publicado: (2022)

Vitamin C modulates the levels of several proteins of the mitochondrial complex III and its activity in the mouse liver
por: Aumailley, Lucie, et al.
Publicado: (2022)

A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis
por: Thériault, Sébastien, et al.
Publicado: (2018)

Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a)
por: Clark, Justin R., et al.
Publicado: (2022)

ApoB/ApoA‐I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study
por: Tastet, Lionel, et al.
Publicado: (2018)

Association of lipoprotein(a) with aortic dissection
por: Yang, Yiheng, et al.
Publicado: (2022)

Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages
por: Lorey, Martina B., et al.
Publicado: (2023)

Enhancer-associated aortic valve stenosis risk locus 1p21.2 alters NFATC2 binding site and promotes fibrogenesis
por: Chignon, Arnaud, et al.
Publicado: (2021)

Autotaxin and Lipoprotein Metabolism in Calcific Aortic Valve Disease
por: Mathieu, Patrick, et al.
Publicado: (2019)

Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis
por: Schnitzler, Johan G., et al.
Publicado: (2019)

Lipoprotein(a) is robustly associated with aortic valve calcium
por: Kaiser, Yannick, et al.
Publicado: (2021)

Serum lipoprotein(a) and bioprosthetic aortic valve degeneration
por: Botezatu, Simona B, et al.
Publicado: (2023)

Apolipoprotein(a) Inhibits In Vitro Tube Formation in Endothelial Cells: Identification of Roles for Kringle V and the Plasminogen Activation System
por: Liu, Lei, et al.
Publicado: (2013)

Determinants of Aortic Stenosis Progression in Bicuspid and Tricuspid Aortic Valves
por: Shen, Mylène, et al.
Publicado: (2022)

A trans‐omic Mendelian randomization study of parental lifespan uncovers novel aging biology and therapeutic candidates for chronic diseases
por: Perrot, Nicolas, et al.
Publicado: (2021)

Genome-wide chromatin contacts of super-enhancer-associated lncRNA identify LINC01013 as a regulator of fibrosis in the aortic valve
por: Chignon, Arnaud, et al.
Publicado: (2022)

The Precipitation of Serum Lipoproteins by Mucopolysaccharides Extracted from Aortic Tissue
por: Amenta, J. S., et al.
Publicado: (1960)

Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification( )
por: Kaiser, Yannick, et al.
Publicado: (2022)

Association of aortic dissection and lipoprotein (a): a meta-analysis
por: Motawea, Karam R., et al.
Publicado: (2023)

Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
por: Kaiser, Yannick, et al.
Publicado: (2022)

Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification
por: Yu, Bin, et al.
Publicado: (2017)

Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease
por: Hu, Jiahui, et al.
Publicado: (2022)

Association of Lipoproteins with Neutrophil Extracellular Traps in Patients with Abdominal Aortic Aneurysm
por: Brandau, Annika, et al.
Publicado: (2022)

Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
por: Burdeynaya, Anna L., et al.
Publicado: (2023)

Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option
por: Maloberti, Alessandro, et al.
Publicado: (2022)

Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis
por: Perrot, Nicolas, et al.
Publicado: (2020)

Lipoprotein(a) As a Potential Predictive Factor for Earlier Aortic Valve Replacement in Patients with Bicuspid Aortic Valve
por: Krzesińska, Aleksandra, et al.
Publicado: (2023)

A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity
por: Rosa, Mickael, et al.
Publicado: (2019)

Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro
Publicado: (1993)

Modified Lipoprotein-Derived Lipid Particles Accumulate in Human Stenotic Aortic Valves
por: Lehti, Satu, et al.
Publicado: (2013)

Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance
por: Vassiliou, Vassilios S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e5qg9eucd8ndjr5f5selh03d9d